Annual report pursuant to Section 13 and 15(d)

Schedule I - Condensed Financial Information of Registrant - Statements of Cash Flows (Details)

v3.22.4
Schedule I - Condensed Financial Information of Registrant - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Condensed Cash Flow Statements      
Operating activities: $ 94,862 $ 82,749 $ 21,216
Investing activities:      
Net cash (used in) investing activities (39,981) (158,614) (9,751)
Financing activities      
Repurchase of vested options     (15,506)
Proceeds from Series A preferred stock issuance, net of issuance costs     346,150
Payments to shareholders for preferred stock Series A     (260,686)
Proceeds from common stock issued upon exercise of stock options 5,803 12,440 780
Proceeds from common stock issued under employee purchase plan 1,734 404 424
Proceeds from issuance of common stock upon initial public offering   269,390  
Proceeds from issuance of common stock in connection to concurrent private placement   30,000  
Payments for offering costs (6) (22,069) (3,610)
Shares repurchased for settlement of employee tax withholdings 10,244 1,802  
Net cash (used in) provided by financing activities (7,884) 264,395 10,385
Effect of exchange rate changes on cash and cash equivalents (784) (200) 203
Net increase in cash, cash equivalents, and restricted cash 46,213 188,330 22,053
Cash, cash equivalents, and restricted cash - Beginning of period 221,725 33,395 11,342
Cash, cash equivalents, and restricted cash - End of period 267,938 221,725 33,395
Noncash investing and financing transactions:      
Common stock issued in connection with acquisition   22,526  
Exchange of common stock for preferred stock     260,686
Treasury stock reissued upon the conversion of Series A preferred stock for common stock   260,686  
Stock-based compensation included in capitalized software development costs 480    
Parent Company | Reportable Legal Entities      
Condensed Cash Flow Statements      
Operating activities: 32,394 67,294 18,214
Investing activities:      
Transfer of funds to subsidiary (32,099) (179,825) (83,000)
Net cash (used in) investing activities (32,099) (179,825) (83,000)
Financing activities      
Repurchase of vested options     (15,506)
Proceeds from Series A preferred stock issuance, net of issuance costs     346,150
Payments to shareholders for preferred stock Series A     (260,686)
Proceeds from common stock issued upon exercise of stock options 5,803 12,440 780
Proceeds from common stock issued under employee purchase plan 1,734 404 424
Proceeds from issuance of common stock upon initial public offering   269,390  
Proceeds from issuance of common stock in connection to concurrent private placement   30,000  
Payments for offering costs   (17,214)  
Shares repurchased for settlement of employee tax withholdings (10,244) (1,802)  
Net cash (used in) provided by financing activities (2,707) 293,218 71,162
Net increase in cash, cash equivalents, and restricted cash (2,412) 180,687 6,376
Cash, cash equivalents, and restricted cash - Beginning of period 187,105 6,418 42
Cash, cash equivalents, and restricted cash - End of period 184,693 187,105 6,418
Noncash investing and financing transactions:      
Common stock issued in connection with acquisition   22,526  
Exchange of common stock for preferred stock     $ 260,686
Treasury stock reissued upon the conversion of Series A preferred stock for common stock   260,686  
Stock-based compensation included in capitalized software development costs 480    
Due to consolidated subsidiaries $ 33,500 $ 68,940